Baseline characteristics of study population
| Total N=464 | Bridging n=166 | Endovascular n=298 | P value | |
| Age, mean (±SD) | 67.7 (±13.28) | 67.1 (±13.42) | 67.9 (±13.22) | 0.517 |
| Sex, male | 303 (65) | 107 (65) | 196 (66) | 0.426 |
| NIHSS, median (IQR) | 18 (10–30) | 17 (9–25) | 18 (10–31) | 0.038 |
| Duration of procedure, min, median (IQR) | 80 (50–120) | 80 (50–115) | 79 (50–125) | 0.451 |
| Onset-to-groin puncture, min, median (IQR)* | 290 (210–401) | 280 (208–370) | 300 (210–422) | 0.175 |
| Onset to recanalisation, min, median (IQR)† | 390 (290–502) | 390 (275–470) | 390 (300–540) | 0.100 |
| TIA/stroke in the last 3 months | 37 (8) | 9 (5) | 28 (9) | 0.088 |
| Atrial fibrillation | 98 (21) | 21 (13) | 77 (26) | <0.001 |
| Hypertension | 315 (68) | 121 (73) | 194 (65) | 0.052 |
| Smoke | 109 (24) | 43 (26) | 66 (22) | 0.211 |
| Diabetes | 84 (18) | 31 (19) | 53 (18) | 0.452 |
| CAD | 38 (8) | 11 (7) | 27 (9) | 0.232 |
| Hypercholesterolaemia | 129 (28) | 49 (30) | 80 (27) | 0.305 |
| Antiplatelet | 136 (29) | 39 (24) | 97 (33) | 0.025 |
| Anticoagulants | 45 (10) | 11 (7) | 34 (11) | 0.064 |
| Statins | 77 (17) | 27 (16) | 50 (17) | 0.498 |
Values are number (%) unless otherwise specified.
*Twenty-eight patients missing data.
†Thirty-two patients missing data.
CAD, coronary artery disease; NIHSS, National Institute of Health Stroke Scale; TIA, transient ischaemic attack.